EU-funded researchers are using silk-based bone marrow “factories” to grow platelets in the lab, helping to lower our dependence on limited donor blood supplies.
By Hannah Docter-Loeb
Every day, hospitals rely on platelet transfusions to stop bleeding, support cancer treatment and help patients recover from surgery and serious illness. Yet one of medicine’s most essential blood products is also among its most fragile.
Unlike red blood cells, which can be
